| Literature DB >> 32010722 |
Lisa Wickerson1,2,3, Sunita Mathur2,3, Dina Brooks2,3, L V Bonetti3,4, Lianne G Singer1,5, John Granton1,5, W Darlene Reid2,3.
Abstract
INTRODUCTION: Individuals with interstitial lung disease (ILD) exhibit reduced exercise capacity and exertional hypoxaemia. The role of peripheral (muscle) limitation to exercise tolerance in ILD is not well studied to date.Entities:
Year: 2020 PMID: 32010722 PMCID: PMC6983499 DOI: 10.1183/23120541.00083-2019
Source DB: PubMed Journal: ERJ Open Res ISSN: 2312-0541
Participant characteristics (n=36)
| 13 | 10 | 13 | |
| 8/5 (38.5%) | 6/4 (40%) | 8/5 (38.5%) | |
| 60±9 | 60±9 | 65±5 | |
| 25±3 | 27±4 | 26±3 | |
| 101±14 | 81±17 | 59±20* | |
| 69 ±14 | 48 ±15* | ||
| 558±107 | 397±71* | ||
| 83±15 | 62±13* | ||
| 148±11 | 136±19 | ||
| 0.43±0.02 | 0.41±0.05 | ||
| 0.45±0.1# | |||
| IPF | 3 | 4 | |
| NSIP | 1 | 3 | |
| IPF/COPD | 2 | ||
| DIP | 1 | ||
| COP | 1 | ||
| NYD | 1 | 1 | |
| Hypersensitivity pneumonia | 2 | ||
| LAM | 1 | ||
| Sjogren's | 2 | ||
| RA-ILD | 1 |
Data are presented as mean±sd unless otherwise stated. ILD: interstitial lung disease; BMI: body mass index; FVC: forced vital capacity; DLCO: diffusing capacity of the lung for carbon monoxide; 6MWD: 6-min walking distance; Hb: haemoglobin; Hct: haematocrit; FIO: inspiratory oxygen fraction; IPF: idiopathic pulmonary fibrosis; NSIP: nonspecific interstitial pneumonia; DIP: desquamative interstitial pneumonia; COP: cryptogenic organising pneumonia; NYD: not yet diagnosed; LAM: lymphangioleiomyomatosis; RA: rheumatoid arthritis. #: during testing, determined from [7]; nasal cannulae regular 3–4 L·min−1 (n=5), nasal cannulae high flow 6–15 L·min−1 (n=5), Oxymizer 4–10 L·min−1 (n=3). *: p≤0.05 for differences between groups.
Incremental limb-loading characteristics (n=36)
| Peak torque N·m | 162±50 | 137±44 | 104±32 | |
| Protocol length min | 12±2 | 10±3 | 10±2 | |
| Maximal % MVIC achieved | 58.5±13 | 52.5±15 | 50.0±10 | |
| Total work performed J | 6328±2515 | 4911±2211 | 3368±1330 | 0.006# |
| Start | 97±1 | 97±2 | 98±2 | |
| End | 97±1 | 95±3 | 95±4 | |
| End HR beats per min | 90±12 | 92±9 | 101±14 | 0.03# |
| End dyspnoea | 1.6±1 | 1.5±1 | 3.3±1 | 0.005# |
| End leg fatigue | 4±2 | 3±1 | 3.5± 1 | |
| Peak torque N·m | 60±19 | 57±18 | 40±18 | |
| Protocol length min | 10.5±1 | 8.8±2 | 7.2±2 | 0.0003¶ |
| Maximal % MVIC achieved | 52.3±7 | 44.1±11 | 36.2±10 | |
| Total work performed J | 3003±1212 | 2514±911 | 1446±811 | 0.001¶ |
| Start | 97±2 | 97±2 | 98±2 | |
| End | 97±1 | 96±2 | 97±2 | |
| End HR beats per min | 85±11 | 88±8 | 94±11 | |
| End dyspnoea | 1.5±1 | 1.5±1 | 3.2±1 | 0.01¶ |
| End arm fatigue | 4±2 | 2.5±2 | 3.5±1 |
Data are presented as mean±sd unless otherwise stated. ILD: interstitial lung disease; MVIC: maximal voluntary isometric contraction; SpO: arterial oxygen saturation measured by pulse oximetry; HR: heart rate; ns: not significant. #: knee-extensor loading: the healthy group had a higher total work than the mild and severe ILD groups; the severe ILD group had a higher end HR and Borg dyspnoea score than the healthy and mild ILD groups. ¶: elbow-flexor loading: the severe ILD group had a lower protocol length and total work than the mild ILD and healthy groups, and a higher end Borg dyspnoea score.
FIGURE 1End-exercise (task failure) muscle oxygen saturation (SmO) over total workload (n=36). a) Knee-extensor loading (KEL); b) elbow-flexor loading (EFL). ILD: interstitial lung disease.
FIGURE 2Change in a) muscle oxygen saturation (SmO), b) oxygenated haemoglobin (O2Hb), c) deoxygenated haemoglobin (HHb) and d) haemoglobin difference (Hb-diff) during incremental knee-extensor limb loading. ILD: interstitial lung disease. *: p≤0.05 for healthy subjects; #: p≤0.05 for severe ILD.
FIGURE 4Change in total haemoglobin (tHb), an estimate of regional blood volume during incremental limb loading. a) Knee-extensor loading; b) elbow-flexor loading. ILD: interstitial lung disease. *: p≤0.05 for healthy subjects; #: p≤0.05 for mild ILD.
FIGURE 3Change in a) muscle oxygen saturation (SmO), b) oxygenated haemoglobin (O2Hb), c) deoxygenated haemoglobin (HHb) and d) haemoglobin difference (Hb-diff) during incremental elbow-flexor limb loading. ILD: interstitial lung disease. *: p≤0.05 for healthy subjects; #: p≤0.05 for mild ILD; ¶: p≤0.05 for severe ILD.